Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-00-049765
Filing Date
2000-11-14
Accepted
2000-11-14 00:00:00
Documents
3
Period of Report
2000-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2029836z10-q.txt 10-Q 39069
2 EXHIBIT 10.34 a2029836zex-10_34.txt EX-10.34 120650
3 EXHIBIT 27.1 a2029836zex-27_1.txt EX-27.1 2300
  Complete submission text file 0000912057-00-049765.txt   163864
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 765481
SIC: 2836 Biological Products, (No Diagnostic Substances)